RITUXIMAB-ARRX vs ROLAPITANT: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RITUXIMAB-ARRX vs ROLAPITANT: Safety Overview
| Metric | RITUXIMAB-ARRX | ROLAPITANT |
|---|---|---|
| Total FAERS Reports | 347 | 873 |
| Deaths Reported | 11 | 252 |
| Death Rate | 3.2% | 28.9% |
| Hospitalizations | 21 | 155 |
| Average Patient Age | 57.0 yrs | 61.4 yrs |
| % Female Patients | 60.6% | 57.5% |
| FDA Approval Date | N/A | Oct 25, 2017 |
| Manufacturer | N/A | TerSera Therapeutics LLC |
| Route | N/A | ORAL |
| Marketing Status | Prescription | Prescription |